Tango Therapeutics Inc Sustainability Reports
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing precision oncology therapies. The company utilizes the genetic principle of synthetic lethality to target underserved cancers, such as those with tumor suppressor gene loss.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
3 reports from 2021 to 2024